177Lu-DOTATATE Shows Promising Efficacy in the Treatment of Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas By Ogkologos - September 2, 2025 220 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the Phase II study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR What to Expect During Recovery From a Bone Marrow Transplant: An... June 20, 2023 Ivonescimab Plus Chemotherapy Significantly Improves PFS in Patients with NSCLC Previously... June 19, 2024 How My Inherited Cancer Diagnosis Has Made Me a Better Oncologist February 23, 2021 Trastuzumab Deruxtecan Demonstrates Efficacy in HER2-positive and HER2-low Advanced Gastric Cancer July 6, 2021 Load more HOT NEWS New hormone treatment for advanced prostate cancer made available in England Intracranial Efficacy of Pembrolizumab in Patients with Brain Metastases T-DM1 is Active and Well Tolerated in Patients with HER2-positive Metastatic... No Glucose? Pancreatic Cancer May Have a Ready Energy Alternative
